“I welcome the broadening of the indications, since I do think psilocybin is likely to get successful in A variety of Conditions,”says David Nutt, author of your Original 2016 study on psilocybin and melancholy, and director in the neuropsychopharmacology unit from the division of brain sciences at Imperial University London. https://martinn418zdi0.ttblogs.com/profile